🔎 Trials Near Me

መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › ጆርጂያ › Atlanta

በAtlanta፣ GA ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 20 ጥናቶች በAtlanta እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory Winship Cancer Institute, Atlanta
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦክቶ 2026 · NCT06586957

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Winship Cancer Institute of Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Emory University (Data Collection Only), Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT05570253

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Piedmont Cancer Institute, Atlanta
  • Northside Hospital, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT05633654

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06400472

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT05846789

ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Emory University Winship Cancer Institute, Atlanta
  • Winship Cancer Institute of Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT06460298

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Northside Hospital, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06926868

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Winship Cancer Institute, Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05377996

Study of XB010 in Subjects With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT06545331

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Winship Cancer Institute / Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT05768932

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Emory University Hospital, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ4 ጁን 2026 · NCT05741164

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Emory University/Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ7 ሜይ 2026 · NCT05877859

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Winship Cancer Institute of Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT01042379

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Emory University Hospital/Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኤፕሪ 2026 · NCT06492759

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory University, Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT02926690

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Winship Cancer Institute - Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጃንዩ 2026 · NCT06926920

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • እና 1 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ጃንዩ 2026 · NCT06324240

A Beta-only IL-2 ImmunoTherapY Study

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Emory - Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2025 · NCT05086692

በሌሎች ከተሞች ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ጥናቶች

በAtlanta ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ7 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።